You are here

Singapore infrastructure a draw for pharma giants

Pharmaceutical firm AbbVie has invested S$400 million to open a manufacturing plant at Tuas Biomedical Park, to support its global manufacturing pipeline.

BT_20181030_MDPHARM_3602406.jpg
The Biopolis complex at Buona Vista. Today, six out of the top 10 drugs globally are made in Singapore, attesting to the city-state's success in attacting big players.

IN 50 YEARS, Singapore has undergone significant transformation from a developing country into a thriving metropolis. Today, with its robust physical and regulatory environment, global connectivity and skilled talent pool, this city-state is a multidisciplinary hub for businesses looking to...

sentifi.com

Market voices on: